News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Elekta AB: Year-End Report May – April 2013/14
May 28, 2014
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Regulatory News:
· Order bookings amounted to SEK 12,253 M (12,117), equivalent to an increase of 5* percent.
· Net sales increased 7* percent to SEK 10,694 M (10,339).
Help employers find you! Check out all the
jobs
and
post your resume
.
Twitter
LinkedIn
Facebook
Email
Print
Earnings
Europe
MORE ON THIS TOPIC
C-suite
Sarepta names former AbbVie R&D exec Michael Severino as next CEO
July 27, 2026
·
3 min read
·
Annalee Armstrong
Earnings
AstraZeneca has no plans to ramp up dealmaking in wake of Wainua failure
July 27, 2026
·
3 min read
·
Tristan Manalac
Mergers & acquisitions
Argenx deepens immuno expertise with $2.2B Forte Biosciences buy
July 27, 2026
·
2 min read
·
Tristan Manalac
Insights
Denmark’s foundation‑fueled biotech boom redraws the Nordic map
July 27, 2026
·
4 min read
·
Jennifer C. Smith-Parker